Dong-A University Hospital
South Korea
- Country
- South Korea
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.damc.or.kr/eng/
Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
Phase 2
Not yet recruiting
- Conditions
- Multiple Myeloma in RelapseMultiple Myeloma, Refractory
- Interventions
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT05909826
Extension of Rapid Response Team Operation Time and Cardiopulmonary Resuscitation Incidence
Completed
- Conditions
- Cardiopulmonary Arrest
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 142088
- Registration Number
- NCT05712915
- Locations
- 🇰🇷
DongA university hospital, Busan, Seo-gu, Korea, Republic of
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma in RelapseMultiple Myeloma, Refractory
- Interventions
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05495620
FOLFIRINOX for 2nd-line Treatment of BTC
Phase 2
Completed
- Conditions
- Biliary Tract Cancer
- Interventions
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT03778593
- Locations
- 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
Marginal Zone Lymphoma Cohort in Korea
- Conditions
- Lymphoma, B-Cell, Marginal Zone
- First Posted Date
- 2016-04-08
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT02732236
- Locations
- 🇰🇷
Sung Yong Oh, Busan, Korea, Republic of
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Phase 2
Completed
- Conditions
- Pancreatic CancerColorectal CancerNon-small Cell Lung Cancer
- Interventions
- Drug: Arm EGF ointment 20 ppmDrug: Arm PlacebosDrug: Arm EGF ointment 1ppm
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT02284139
- Locations
- 🇰🇷
Sung Yong Oh, Busan, Korea, Republic of
XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)
Phase 3
Terminated
- Conditions
- Gastric Carcinoma Stage IV
- Interventions
- Drug: FOLFOXDrug: XELOX
- First Posted Date
- 2012-12-13
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT01748851
- Locations
- 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
EGF Ointment for Erlotinib Skin Lesion
Phase 2
Completed
- Conditions
- Non-small Cell Lung CancerPancreatic Cancer
- Interventions
- Drug: Epidermal growth factor (EGF) ointment
- First Posted Date
- 2012-05-08
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT01593995
- Locations
- 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2016-04-11
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT01213095
- Locations
- 🇰🇷
Sung Yong Oh, Busan, Korea, Republic of
FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)
Phase 2
Completed
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2010-06-08
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01138904
- Locations
- 🇰🇷
Sung Yong Oh, Busan, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath